TCT 678: Long-term Follow-up From the Use of Sirolimus Coated Balloons in De-novo Coronary lesions in a Real-World Population from 3 High Volume European Centers
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Concept Medical; Shockwave Medical